Commonwealth Equity Services LLC Buys 5,000 Shares of Vivos Therapeutics, Inc. (NASDAQ:VVOS)

Commonwealth Equity Services LLC increased its stake in shares of Vivos Therapeutics, Inc. (NASDAQ:VVOS) by 23.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 26,000 shares of the company’s stock after acquiring an additional 5,000 shares during the quarter. Commonwealth Equity Services LLC owned about 0.44% of Vivos Therapeutics worth $112,000 at the end of the most recent quarter.

Separately, Cutter & CO Brokerage Inc. bought a new position in shares of Vivos Therapeutics during the 4th quarter valued at approximately $163,000. Institutional investors own 26.35% of the company’s stock.

Vivos Therapeutics Price Performance

NASDAQ VVOS opened at $2.29 on Friday. The company has a market cap of $13.49 million, a price-to-earnings ratio of -0.40 and a beta of 7.31. The stock’s fifty day moving average price is $3.32 and its 200 day moving average price is $3.55. Vivos Therapeutics, Inc. has a 1 year low of $1.91 and a 1 year high of $6.28.

Vivos Therapeutics (NASDAQ:VVOS) last issued its earnings results on Thursday, March 27th. The company reported ($0.28) EPS for the quarter, topping analysts’ consensus estimates of ($0.43) by $0.15. Vivos Therapeutics had a negative return on equity of 335.04% and a negative net margin of 86.19%. The firm had revenue of $3.70 million for the quarter, compared to the consensus estimate of $3.89 million. Research analysts expect that Vivos Therapeutics, Inc. will post -1.79 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, Alliance Global Partners reaffirmed a “buy” rating on shares of Vivos Therapeutics in a research report on Tuesday, April 1st.

About Vivos Therapeutics

Vivos Therapeutics, Inc, a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.